Qiu-Yue Lin Selected Research

Qiu-Yue Lin Research Topics

Disease

7	Fibrosis (Cirrhosis) 02/2022 - 01/2018
7	Inflammation (Inflammations) 01/2022 - 01/2018
7	Hypertrophy 01/2022 - 01/2018
6	Cardiomegaly (Heart Hypertrophy) 01/2021 - 01/2018
5	Hypertension (High Blood Pressure) 01/2022 - 01/2018
3	Heart Diseases (Heart Disease) 02/2022 - 12/2019
3	Heart Failure 01/2022 - 06/2019
3	Atherosclerosis 01/2022 - 12/2019
2	Cardiac Edema 01/2022 - 01/2021
2	Hypertensive Retinopathy 01/2020 - 01/2018
2	Cardiovascular Diseases (Cardiovascular Disease) 12/2019 - 01/2018
2	Neoplasms (Cancer) 01/2014 - 06/2013
1	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 02/2022
1	Vascular Remodeling 01/2022
1	Edema (Dropsy) 01/2022
1	Alcoholism (Alcohol Abuse) 01/2020
1	Myocardial Infarction 12/2019
1	Reperfusion Injury 12/2019
1	Autoimmune Diseases (Autoimmune Disease) 06/2019
1	Atrial Remodeling 01/2019
1	Atrial Fibrillation 01/2019
1	Vascular System Injuries 01/2018
1	Carcinogenesis 01/2018
1	Hepatocellular Carcinoma (Hepatoma) 09/2012

Drug/Important Bio-Agent (IBA)

6	Angiotensin IIIBA 01/2022 - 01/2018
3	Proteasome Endopeptidase Complex (Proteasome)IBA 02/2022 - 01/2018
3	Superoxides (Superoxide)IBA 02/2022 - 01/2018
3	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 01/2018
3	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2018
2	ApolipoproteinsIBA 01/2022 - 01/2020
2	Vascular Endothelial Growth Factor Receptor-3 (Flt 4)IBA 01/2022 - 01/2021
2	CytokinesIBA 01/2021 - 06/2019
2	Connexin 43 (Connexin43)IBA 01/2021 - 01/2019
2	Neutralizing AntibodiesIBA 01/2020 - 01/2018
2	Immunoglobulin G (IgG)IBA 01/2020 - 01/2018
2	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 01/2020 - 12/2019
2	ResveratrolIBA 12/2019 - 01/2019
2	Pharmaceutical PreparationsIBA 01/2014 - 06/2013
1	Therapeutic UsesIBA 02/2022
1	epoxomicinIBA 01/2022
1	cadherin 5IBA 01/2022
1	AngiotensinsIBA 01/2022
1	Gallic AcidIBA 01/2022
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 01/2022
1	p38 Mitogen-Activated Protein KinasesIBA 01/2022
1	Proteasome InhibitorsIBA 01/2022
1	Glucose (Dextrose)FDA LinkGeneric 01/2021
1	Endoplasmic Reticulum Chaperone BiPIBA 01/2021
1	Vascular Endothelial Growth Factor CIBA 01/2021
1	CalcineurinIBA 01/2021
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2020
1	CholesterolIBA 01/2020
1	Apolipoproteins E (ApoE)IBA 01/2020
1	oxidized low density lipoproteinIBA 01/2020
1	c-Mer Tyrosine KinaseIBA 01/2020
1	Chymotrypsin FDA Link 01/2020
1	Immunoglobulins (Immunoglobulin)IBA 12/2019
1	Rituximab (Mabthera)FDA Link 06/2019
1	AntibodiesIBA 06/2019
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2019
1	NADPH Oxidases (NAD(P)H oxidase)IBA 01/2019
1	VO-OHpicIBA 01/2019
1	ChemokinesIBA 01/2018
1	Chemokine ReceptorsIBA 01/2018
1	Interleukin-8B ReceptorsIBA 01/2018
1	TrypsinIBA 01/2018
1	Retinaldehyde (Retinal)IBA 01/2018
1	Chemokine CXCL1IBA 01/2018
1	N- (3,5- bis(trifluoromethyl)phenyl)- 5- chloro- 2- hydroxybenzamideIBA 01/2018
1	DNA (Deoxyribonucleic Acid)IBA 01/2018
1	Anaphase-Promoting Complex-CyclosomeIBA 01/2018
1	CopperIBA 09/2012